SNGX
Soligenix, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.38
−0.84%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- -$0.12
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- -$0.12
- EPS estimate
- -$0.15
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +8.3%
- Revenue beats (12Q)
- 3
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026